Participants
Who attends the Convergence Forum?
Pharmaceutical Execs,
CIOs, CTOs, CEOs
Biotech Entrepreneurs,
Start-up Companies
Innovators,
Medical Device Inventors
Life Science Investors,
Bankers, Backers
Academic Researchers,
Analysts, Journalists
When fields converge
What opportunities get created as fields converge? What challenges surface as markets, policies, and investing dynamics shift? What new scientific discoveries are potential game-changers? Convergence exists to explore those questions (and many others), with a high-level audience interested in what’s happening in the rapidly-converging worlds of biotech, pharma, healthcare, medical devices, and the Internet.
The Convergence Forum fosters real debate and discussion among audiences that are every bit as high-level as the speakers. The programs provide an opportunity for participants to make important new contacts, do business, explore important new directions in research, delve deeply into what it takes to maintain competitive advantage in a fast-changing world, and leave feeling recharged.
Companies that will be represented at the 2018 Convergence Forum include:
AbbVie Ventures
Advanced Regenerative Manufacturing Institute
Alexandria Real Estate Equities
Aquilo Partners
Arrakis Therapeutics
Axcella Health, Inc.
Back Bay Life Science Advisors
Baillie Gifford
Biogen
BioInnovation Capital
BioVentures Investors
Boston Pharmaceuticals
Broad Institute
Canaan Partners
CBT Advisors
Cerevance, Inc.
Churchill Pharma LLC
CRISPR Therapeutics
DeuteRx
EMD Serono
Emerging BioCommunications
Empiriko
Evotec AG
Flagship Pioneering
Foley & Lardner
F-Prime Capital Partners
GNS Healthcare
GrayBella Capital
Halloran Consulting Group
Harvard Medical School
Ipsen
IRX Therapeutics
Johnson & Johnson
Kaleido Biosciences
Koch Institute at MIT
Longitude Capital
Lysosomal Therapeutics
MacDougall Biomedical Communications
Merck
Merieux Developpement
Mersana Therapeutics
Mirata Pharmaceuticals
Moderna Therapeutics
Momenta Pharmaceuticals
MRL Ventures Fund
Myovant
Navitor Pharmaceuticals
NGM Biopharmaceuticals
Nitto Avecia Inc.
Northeastern University
Obsidian Therapeutic
Omega Funds
Oncorus
Ovid Therapeutics Inc.
Oxford Finance LLC
Park Square Executive Search
Partners HealthCare Innovation
PBL Assay Science
Potenza Therapuetics
Prognos
RA Capital Management
RMG Associates, LLC
Sanofi
Stat
Stromasys
Sucampo Pharmaceuticals
Sunovion Pharmaceuticals Inc.
SV Health Investors
Synlogic Therapeutics
Takeda Pharmaceuticals International
Tarveda Therapeutics
Teva Pharmaceuticals
Third Rock Ventures
Tilos Therapeutics
TriNetX
USB
Vertex Pharmaceuticals Inc.
Wolfe Laboratories
Xontogeny
XTuit Pharmaceuticals, Inc.
Zafgen
Request an invite for the next Convergence Forum. Please call 617-437-1400 or email Alyssa Stern at astern@convergenceforum.com for additional information.